AHRQ adds new guides to supplement ischemic heart disease comparative effectiveness review
The Agency for Health Care Research and Quality (AHRQ) Effective Health Care (EHC) Program has added new materials relevant to the comparative effectiveness review, Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease.
Learn how you can personalize your interactions with and share what you learn on the EHC Program Web site. Visit http://www.effectivehealthcare.ahrq.gov/index.cfm/personalization-and-social-media-tools.
Return to Contents
Proceed to Next Article